308 related articles for article (PubMed ID: 11647947)
1. Profits and ethics clash in research on genetic coding.
Fisher LM
N Y Times Web; 1994 Jan; ():1, 18. PubMed ID: 11647947
[No Abstract] [Full Text] [Related]
2. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
Lehrman S
Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
[No Abstract] [Full Text] [Related]
3. Money is putting people at risk in biomedical research.
Andrews LB
Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
[No Abstract] [Full Text] [Related]
4. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
Bulleit TN
J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
[No Abstract] [Full Text] [Related]
5. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
6. Ethical values in the education of biomedical researchers.
Heitman E
Hastings Cent Rep; 2000; 30(4 Suppl):S40-4. PubMed ID: 11658244
[No Abstract] [Full Text] [Related]
7. Bioethics and applied biomaterials.
Saha S; Saha P
J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924
[No Abstract] [Full Text] [Related]
8. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
9. Conflicts of interest.
Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
[No Abstract] [Full Text] [Related]
10. All rights reserved: how the gene-patenting race is affecting science.
Wuethrich B
Sci News; 1993 Sep; 144(10):154-7. PubMed ID: 11659682
[No Abstract] [Full Text] [Related]
11. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
12. Health chief assails a research deal.
Hilts PJ
N Y Times Web; 1993 Mar; ():A12. PubMed ID: 11646979
[No Abstract] [Full Text] [Related]
13. Patients could lose out in tussle over gene bank.
Patel T
New Sci; 1994 Mar; 141(1918):9. PubMed ID: 11659725
[No Abstract] [Full Text] [Related]
14. University-industry relationships in genetic research: potential opportunities and pitfalls.
Walsh ME; Graber GC; Wolfe AK
Account Res; 1997; 5(4):265-82. PubMed ID: 11656993
[No Abstract] [Full Text] [Related]
15. The role and responsibility of industry in research.
Lasagna L
Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199
[No Abstract] [Full Text] [Related]
16. The dream of the human genome: doubts about the Human Genome Project.
Lewontin R
New York Rev Books; 1992 May; 39(10):31-40. PubMed ID: 11659413
[No Abstract] [Full Text] [Related]
17. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
Siris ES; Burrell CD
IRB; 1983; 5(6):1-5. PubMed ID: 11649526
[No Abstract] [Full Text] [Related]
18. Academic-corporate ties in biotechnology: a quantitative study.
Krimsky S; Ennis JG; Weissman R
Sci Technol Human Values; 1991; 16(3):275-87. PubMed ID: 11652031
[No Abstract] [Full Text] [Related]
19. Drug trials hide conflicts for doctors.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():1, 34. PubMed ID: 11648114
[No Abstract] [Full Text] [Related]
20. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
